Skip to main content
  • Main menu
  • User menu
  • Search

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleResearch

Establishing Acceptable Limits of Residual DNA

Harry Yang
PDA Journal of Pharmaceutical Science and Technology March 2013, 67 (2) 155-163; DOI: https://doi.org/10.5731/pdajpst.2013.00910
Harry Yang
MedImmune LLC, Gaithersburg, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 67 no. 2 155-163
DOI 
https://doi.org/10.5731/pdajpst.2013.00910
PubMed 
23569076

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online April 8, 2013.

Copyright & Usage 
© PDA, Inc. 2013

Author Information

  1. Harry Yang
  1. MedImmune LLC, Gaithersburg, MD
  1. YangH@MedImmune.com
View Full Text

Cited By...

  • 41 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Vaccine Safety: Myths and Misinformation
    Sarah Geoghegan, Kevin P. O’Callaghan, Paul A. Offit
    Frontiers in Microbiology 2020 11
  • Manufacturing a chimpanzee adenovirus‐vectored SARS‐CoV‐2 vaccine to meet global needs
    Carina C. D. Joe, Jinlin Jiang, Thomas Linke, Yuanyuan Li, Sofiya Fedosyuk, Gaurav Gupta, Adam Berg, Rameswara R. Segireddy, David Mainwaring, Amar Joshi, Paul Cashen, Byron Rees, Nitin Chopra, Piergiuseppe Nestola, Jonathan Humphreys, Sarah Davies, Nick Smith, Scott Bruce, Dennis Verbart, Daan Bormans, Carol Knevelman, Mark Woodyer, Lee Davies, Lisa Cooper, Maria Kapanidou, Nicole Bleckwenn, Daniel Pappas, Teresa Lambe, Daniel C. Smith, Catherine M. Green, Raghavan Venkat, Adam J. Ritchie, Sarah C. Gilbert, Richard Turner, Alexander D. Douglas
    Biotechnology and Bioengineering 2022 119 1
  • Identification and tracking of problematic host cell proteins removed by a synthetic, highly functionalized nonwoven media in downstream bioprocessing of monoclonal antibodies
    S. Gilgunn, H. El-Sabbahy, S. Albrecht, M. Gaikwad, K. Corrigan, L. Deakin, G. Jellum, J. Bones
    Journal of Chromatography A 2019 1595
  • Membrane‐Based Approach for the Downstream Processing of Influenza Virus‐Like Particles
    Sofia B. Carvalho, Ricardo J. S. Silva, Mafalda G. Moleirinho, Bárbara Cunha, Ana S. Moreira, Alex Xenopoulos, Paula M. Alves, Manuel J. T. Carrondo, Cristina Peixoto
    Biotechnology Journal 2019 14 8
  • Falsification of biotechnology drugs: current dangers and/or future disasters?
    Steven Janvier, Bart De Spiegeleer, Celine Vanhee, Eric Deconinck
    Journal of Pharmaceutical and Biomedical Analysis 2018 161
  • Optimization of the quality by design approach for gene therapy products: A case study for adeno-associated viral vectors
    Toshimitsu Tanaka, Hideki Hanaoka, Shingo Sakurai
    European Journal of Pharmaceutics and Biopharmaceutics 2020 155
  • A direct droplet digital PCR method for quantification of residual DNA in protein drugs produced in yeast cells
    Musaddeq Hussain, Rebecca Fantuzzo, Suzanne Mercorelli, Constance Cullen
    Journal of Pharmaceutical and Biomedical Analysis 2016 123
  • Antibody-Drug Conjugate Overview: a State-of-the-art Manufacturing Process and Control Strategy
    Meng Li, Xueyu Zhao, Chuanfei Yu, Lan Wang
    Pharmaceutical Research 2024 41 3
  • Membrane Chromatography-Based Downstream Processing for Cell-Culture Produced Influenza Vaccines
    Zeyu Yang, Xingge Xu, Cristina A. T. Silva, Omar Farnos, Alina Venereo-Sanchez, Cécile Toussaint, Shantoshini Dash, Irene González-Domínguez, Alice Bernier, Olivier Henry, Amine Kamen
    Vaccines 2022 10 8
  • Safety risk management for low molecular weight process‐related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential
    Haibin Luo, Yuling Li, David Robbins, Sheau‐Chiann Wang, Guoling Xi, Matthew Cox, Simone M. Nicholson, Chenghong Wei, Timothy M. Pabst, William K. Wang
    Biotechnology Progress 2021 37 3
  • Single-step rapid chromatographic purification and characterization of clinical stage oncolytic VSV-GP
    Saurabh Gautam, Dongyue Xin, Alan Pardo Garcia, Bart Spiesschaert
    Frontiers in Bioengineering and Biotechnology 2022 10
  • Universal real-time PCR assay for quantitation and size evaluation of residual cell DNA in human viral vaccines
    Murielle André, Sylviane Reghin, Estelle Boussard, Laurent Lempereur, Stéphane Maisonneuve
    Biologicals 2016 44 3
  • Rapid authentication of pharmaceuticals via DNA tagging and field detection
    Lawrence Jung, Michael E. Hogan, Yuhua Sun, Benjamin Minghwa Liang, James A. Hayward, Richard C. Willson
    PLOS ONE 2019 14 6
  • Method validation of Q-PCR detection of host residual DNA in antibody drug based on protein A magnetic beads
    Xiao-zhi Liu, Bin Zhang, Wei Zhao, Geng Li, Mei-ling Zhou, Jing-shuang Wei, Jing-hua Zhou, Jian Gao, Zhi-ming Wang
    Biologicals 2019 62
  • Purification processes of live virus vaccine candidates expressed in adherent Vero cell lines via multimodal chromatography in flowthrough mode
    Spyridon Konstantinidis, Murphy R. Poplyk, Wanli (Justin) Ma, Devan Reilly, Young Zhang, Jamin Wang, Rachel Thompson, Alyssa Stiving, Michael A. Winters, Sheng‐Ching Wang, Adam Kristopeit
    Biotechnology and Bioengineering 2024 121 8
  • A Droplet Digital PCR Method for CHO Host Residual DNA Quantification in Biologic Drugs
    Musaddeq Hussain
    Journal of Analytical & Pharmaceutical Research 2017 4 3
  • Determining the efficacy of disinfectants at nucleic acid degradation
    Rachael C Wilkinson, Kirsty Meldrum, Caitlin J Maggs, Nerissa E Thomas, Bethan R Thomas, Natalie De Mello, Naomi Joyce
    Journal of Applied Microbiology 2023 134 11
  • Basic regulatory science behind drug substance and drug product specifications of monoclonal antibodies and other protein therapeutics
    Patanachai K. Limpikirati, Sorrayut Mongkoltipparat, Thinnaphat Denchaipradit, Nathathai Siwasophonpong, Wudthipong Pornnopparat, Parawan Ramanandana, Phumrapee Pianpaktr, Songsak Tongchusak, Maoxin Tim Tian, Trairak Pisitkun
    Journal of Pharmaceutical Analysis 2024 14 6
  • Peptide ligands for the affinity purification of adenovirus from HEK293 and vero cell lysates
    Yuxuan Wu, Eduardo Barbieri, Ryan E. Kilgore, Brandyn D. Moore, Wenning Chu, Gina N. Mollica, Michael A. Daniele, Stefano Menegatti
    Journal of Chromatography A 2024 1736
  • Therapeutic Enzymes: Function and Clinical Implications
    David Gervais
    2019 1148
  • A novel method for quantitation of AAV genome integrity using duplex digital PCR
    Lauren Tereshko, Xiaohui Zhao, Jake Gagnon, Tinchi Lin, Trevor Ewald, Yu Wang, Marina Feschenko, Cullen Mason, Simone Agostini
    PLOS ONE 2023 18 12
  • Cell Therapy
    Adrian P. Gee
    2022
  • Determination of linearized pDNA template in mRNA production process using HPLC
    Marta Leban, Tina Vodopivec Seravalli, Martina Hauer, Ernst Böhm, Nina Mencin, Sandra Potušek, Andrej Thompson, Jurij Trontelj, Aleš Štrancar, Rok Sekirnik
    Analytical and Bioanalytical Chemistry 2024 416 10
  • Manufacturing of Viral Gene Therapies
    G. Anthony Ramirez, Mehdi Gasmi
    International Ophthalmology Clinics 2021 61 3
  • Viral, Parasitic, Bacterial, and Fungal Infections
    Santiago M.C. Lopez, Alice I. Sato, Archana Chatterjee
    2023
  • Bacteriophage Therapy
    Tiffany Luong, Andrew D. Sue, Dwayne R. Roach
    2024 2734
  • Chip-based digital PCR as a direct quantification method for residual DNA in mRNA drugs
    Wenchao Fan, Lan Zhao, Lei Yu, Yong Zhou
    Journal of Pharmaceutical and Biomedical Analysis 2024 238
  • Dual-mode action of scalable, high-quality engineered stem cell-derived SIRPα-extracellular vesicles for treating acute liver failure
    Seohyun Kim, Yoon Kyoung Kim, Seonghyun Kim, Yong-Soon Choi, Inkyu Lee, Hyemin Joo, Jaehyun Kim, Minjeong Kwon, Seryoung Park, Min Kyoung Jo, Yoonjeong Choi, Theresa D’Souza, Jae Woong Jung, Elie Zakhem, Stephen Lenzini, Jiwan Woo, Hongyoon Choi, Jeongbin Park, Seung-Yoon Park, Gi Beom Kim, Gi-Hoon Nam, In-San Kim
    Nature Communications 2025 16 1
  • Information Management and Big Data
    Rebecca A. Stachowicz
    2020 1070
  • Isothermal droplet digital PCR method for quantification of CHO residual DNA
    Musaddeq Hussain
    Journal of Pharmaceutical and Biomedical Analysis 2022 211
  • Size distribution analysis of residual host cell DNA fragments in lentivirus by CGE‐LIF
    Wentao Wang, Tie Gao, Ji Luo, Lihai Guo, Xiang Li, Yan Li, Hongxu Chen
    ELECTROPHORESIS 2023 44 3-4
  • Adaptation of an rVSV Ebola vaccine purification process for rapid development of a viral vaccine candidate for SARS‐CoV‐2
    Laura E. Kuczynski, James R. Shallow, Matthew P. Watson, Michael L. Homsy, Thomas Svab, Ashley Gruber, Richard R. Rustandi, Jianfang Hu, Michael A. Winters
    Biotechnology Journal 2024 19 1
  • Biological Safety
    Dawn P. Wooley
    2016
  • Development of a Recombinant Omicron BA.1 Subunit Vaccine Candidate in Pichia pastoris
    Sibel Kalyoncu, Dogu Sayili, Ayca Zeybek Kuyucu, Hakan Soyturk, Seyda Gullu, Busra Ersayan, Ibrahim Oguzhan Tarman, Mehmet Ender Avci, Olcay Mert, Umut Haskok, Ege Tekin, Huseyin Akinturk, Ridvan Orkut, Aysegul Demirtas, Idil Tilmensagir, Ceren Ulker, Bilgi Gungor, Mehmet Inan
    Microbial Biotechnology 2025 18 1
  • Evaluation of the Efficacy of the Vaccine Production Process in Removing Residual Host Cell DNA from the Vero Cell Rabies Vaccine
    Jia Li, Ruowen Pan, Fengyi Yue, Tie Gao, Xiaohong Wu, Leitai Shi, Yunpeng Wang, Danhua Zhao, Zhaohui Lan, Hongxu Chen, Qiang Ye, Shouchun Cao
    Vaccines 2024 12 12
  • Integrating Affinity Chromatography in the Platform Process for Adenovirus Purification
    Yuxuan Wu, Eduardo Barbieri, William K. Smith, Arianna Minzoni, Ryan E. Kilgore, Wenning Chu, Michael A. Daniele, Stefano Menegatti
    Biotechnology and Bioengineering 2025
  • Membrane Filtration of Nanoscale Biomaterials: Model System and Membrane Performance Evaluation for AAV2 Viral Vector Clarification and Recovery
    Mara Leach, Kearstin Edmonds, Emily Ingram, Rebecca Dutch, Ranil Wickramasinghe, Malgorzata Chwatko, Dibakar Bhattacharyya
    Nanomaterials 2025 15 4
  • Process and quality considerations for recombinant adeno-associated virus manufacturing platforms
    Min Tae Park, Amrisha Verma, Clifford A. Froelich, Seyed Pouria Motevalian
    Trends in Biotechnology 2025
  • Protein Therapeutics
    Kripa Ram, Diane Hatton, Sanjeev Ahuja, Jean Bender, Alan Hunter, Richard Turner
    2016 21
  • Quality assessment strategy development and analytical method selection of GMP grade biological drugs for gene and cell therapy
    Quan-en Yang, Nicole Lee, Nicole Johnson, Jennifer Hong, Jenny (Qinghua) Zhao, Xiulian Sun, Jian Zhang
    BBA Advances 2025 7
  • Safety assessment of drug impurities for patient safety: A comprehensive review
    Frank Liu
    Regulatory Toxicology and Pharmacology 2024 153
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 67 (2)
PDA Journal of Pharmaceutical Science and Technology
Vol. 67, Issue 2
March/April 2013
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Share
Establishing Acceptable Limits of Residual DNA
Harry Yang
PDA Journal of Pharmaceutical Science and Technology Mar 2013, 67 (2) 155-163; DOI: 10.5731/pdajpst.2013.00910
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget

Jump to section

  • Article
    • Abstract
    • Introduction
    • Regulatory Specifications
    • Methods of Risk Assessment
    • Risk-Based Specifications
    • Discussion and Conclusions
    • Acknowledgements
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Integrating affinity chromatography in the platform process for Adenovirus purification
  • Dual-mode action of scalable, high-quality engineered stem cell-derived SIRP{alpha}-extracellular vesicles for treating acute liver failure
  • A Bayesian Approach to Residual Host Cell DNA Safety Assessment
  • Google Scholar

More in this TOC Section

  • A proof-of-concept study on a universal standard kit to evaluate the risks of inspectors for their foundational ability of visual inspection of injectable drug products
  • Understanding Alignment in the Execution of Extractable Screening Studies Between Laboratories: Results of the ELSIE Lab Practices Sub-Team Industry Surveys
  • Definition of Particle Visibility Threshold in Parenteral Drug Products—Towards Standardization of Visual Inspection Operator Qualification
Show more Research

Similar Articles

Keywords

  • Acceptable limits
  • Infectivity
  • Oncogenicity
  • Residual DNA
  • Risk-based assessment

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire
Alerts for this Article
Sign In to Email Alerts with your Email Address
Email this Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Establishing Acceptable Limits of Residual DNA
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 15 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Establishing Acceptable Limits of Residual DNA
Harry Yang
PDA Journal of Pharmaceutical Science and Technology Mar 2013, 67 (2) 155-163; DOI: 10.5731/pdajpst.2013.00910

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

We use cookies on this site to enhance your user experience

By clicking any link on this page you are giving your consent for us to set cookies.